These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12662005)

  • 21. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
    Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
    Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA; Campbell IA; Banks J; Gelder CM; Prescott RJ; Smith AP
    Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
    Randhawa K; Smethurst P; Soo Hoo GW
    South Med J; 2010 Aug; 103(8):828-30. PubMed ID: 20622732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium shinjukuense lung disease that was successfully treated with antituberculous drugs.
    Watanabe K; Shinkai M; Yamaguchi N; Shinoda M; Hara Y; Ishigatsubo Y; Kaneko T
    Intern Med; 2013; 52(23):2653-5. PubMed ID: 24292757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium malmoense lymphadenitis in Spain: first two cases in immunocompetent patients.
    López-Calleja AI; Lezcano MA; Samper S; de Juan F; Revillo MJ
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):567-9. PubMed ID: 15257445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium malmoense infection. An unusual cause of wrist swelling.
    Syed AA; O'Flanagan J
    J Hand Surg Br; 1998 Dec; 23(6):811-2. PubMed ID: 9888690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.
    Shiraishi Y; Katsuragi N; Kita H; Hyogotani A; Saito MH; Shimoda K
    Ann Thorac Surg; 2013 Jul; 96(1):287-91. PubMed ID: 23618520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycobacterium malmoense infection in an immunocompetent patient].
    Guiot J; Ramaut M; Massart B; Louis R
    Rev Med Liege; 2009; 64(7-8):390-3. PubMed ID: 19777918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
    Popovic V; Arar D; Popovic DR; Barisic I; Tonkic M; Peric I; Novak A; Rubic Z; Katalinic-Jankovic V; Makek MJ; Goic-Barisic I
    Folia Microbiol (Praha); 2018 Mar; 63(2):249-252. PubMed ID: 28913757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Other Nontuberculous Mycobacteria.
    Basille D; Jounieaux V; Andréjak C
    Semin Respir Crit Care Med; 2018 Jun; 39(3):377-382. PubMed ID: 30071552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis.
    Diel R; Ringshausen F; Richter E; Welker L; Schmitz J; Nienhaus A
    Chest; 2017 Jul; 152(1):120-142. PubMed ID: 28461147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian Amazon.
    Monteiro JTC; Lima KVB; Barretto AR; Furlaneto IP; Gonçalves GM; Costa ARFD; Lopes ML; Dalcolmo MP
    J Bras Pneumol; 2018 Apr; 44(2):93-98. PubMed ID: 29791556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia.
    Baird TM; Carter R; Eather G; Thomson R
    Emerg Infect Dis; 2017 Nov; 23(11):1919-1922. PubMed ID: 29048290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
    Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium kansasii pulmonary diseases in Korea.
    Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
    J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.